ARENACCIO, CLAUDIA
 Distribuzione geografica
Continente #
NA - Nord America 1.656
EU - Europa 568
AS - Asia 273
AF - Africa 26
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.527
Nazione #
US - Stati Uniti d'America 1.655
CN - Cina 225
GB - Regno Unito 158
SE - Svezia 120
DE - Germania 85
FI - Finlandia 51
IE - Irlanda 33
IT - Italia 33
UA - Ucraina 31
VN - Vietnam 26
CI - Costa d'Avorio 24
DK - Danimarca 18
RU - Federazione Russa 18
TR - Turchia 17
AL - Albania 12
IN - India 5
AU - Australia 3
NL - Olanda 3
FR - Francia 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
CA - Canada 1
EE - Estonia 1
ME - Montenegro 1
RO - Romania 1
Totale 2.527
Città #
Fairfield 286
Woodbridge 245
Ashburn 159
Chandler 146
Southend 138
Houston 128
Wilmington 100
Seattle 99
Cambridge 98
Ann Arbor 63
Dearborn 49
Helsinki 39
Nanjing 37
Beijing 34
Jacksonville 34
Shanghai 33
Dublin 31
Princeton 29
Dong Ket 26
Redwood City 18
Shenyang 18
Izmir 17
Jinan 13
Hebei 12
San Diego 12
Changsha 11
Plano 10
Rome 10
Jiaxing 9
Kunming 9
Nanchang 8
Boardman 7
Tianjin 6
Böblingen 5
Guangzhou 5
Falls Church 4
Haikou 4
Milan 4
Pune 4
Bremen 3
Flushing 3
Fort Worth 3
Hangzhou 3
London 3
Los Angeles 3
New York 3
San Paolo di Civitate 3
Taizhou 3
Zhengzhou 3
Altamura 2
Auburn Hills 2
Cervinara 2
Chiswick 2
Dakar 2
Esslingen am Neckar 2
Hefei 2
Hounslow 2
Kilburn 2
Lanzhou 2
Mentana 2
Mountain View 2
Nagold 2
New Bedfont 2
Norwalk 2
Taiyuan 2
Trento 2
Washington 2
Acton 1
Bari 1
Bethesda 1
Buffalo 1
Cupertino 1
Dallas 1
Edinburgh 1
Greenwich 1
Groningen 1
Hanover 1
Melbourne 1
Mumbai 1
Nanning 1
Naples 1
Ningbo 1
North York 1
Orange 1
Paris 1
Podgorica 1
Radeberg 1
Redmond 1
Tallinn 1
Timisoara 1
Verona 1
Wandsworth 1
Totale 2.051
Nome #
Exosomes from human immunodeficiency virus type 1 (HIV-1)-infected cells license quiescent CD4+ T lymphocytes to replicate HIV-1 through a Nef- and ADAM17-dependent mechanism. 196
The ADAR1 editing enzyme is encapsidated into HIV-1 virions 175
MiR-146a controls CXCR4 expression in a pathway that involves PLZF and can be used to inhibit HIV-1 infection of CD4+ T lymphocytes 166
The CD8⁺ T Cell-Mediated Immunity Induced by HPV-E6 Uploaded in Engineered Exosomes Is Improved by ISCOMATRIX(TM) Adjuvant 161
HIV-1 Nef Impairs Key Functional Activities in Human Macrophages through CD36 Downregulation 157
HIV-1-infected cells transiently express lentiviral RNA shuttled by exosomes 155
Uncovering the role of defective HIV-1 in spreading viral infection 146
The Contribution of Extracellular Nef to HIV-Induced Pathogenesis 145
Latent HIV-1 is activated by exosomes from cells infected with either replication-competent or defective HIV-1 140
Surface-bound Tat inhibits antigen-specific CD8(+) T-cell activation in an integrin-dependent manner 133
HPV-E7 delivered by engineered exosomes elicits a protective CD8+ T cell-mediated immune response 133
Cell activation and HIV-1 replication in unstimulated CD4+ T lymphocytes ingesting exosomes from cells expressing defective HIV-1 130
The intracellular delivery of anti-HPV16 E7 scFvs through engineered extracellular vesicles inhibits the proliferation of HPV-infected cells 99
DNA Vectors Generating Engineered Exosomes Potential CTL Vaccine Candidates Against AIDS, Hepatitis B, and Tumors 78
Antitumor HPV E7-specific CTL activity elicited by in vivo engineered exosomes produced through DNA inoculation 66
Extracellular vesicle-mediated intercellular communication in HIV-1 infection and its role in the reservoir maintenance 63
Trans-dissemination of exosomes from HIV-1-infected cells fosters both HIV-1 trans-infection in resting CD4+ T lymphocytes and reactivation of the HIV-1 reservoir 63
Engineered exosomes emerging from muscle cells break immune tolerance to HER2 in transgenic mice and induce antigen-specific CTLs upon challenge by human dendritic cells 60
HIV‐1 Nef Protein Affects Cytokine and Extracellular Vesicles Production in the GEN2.2 Plasmacytoid Dendritic Cell Line 58
Exosomes in Therapy: Engineering, Pharmacokinetics and Future Applications 57
N-terminal fatty acids of NEFmut are required for the CD8+ t-cell immunogenicity of in vivo engineered extracellular vesicles 52
An Exosome-Based Vaccine Platform Imparts Cytotoxic T Lymphocyte Immunity Against Viral Antigens 48
Development of a novel human phage display-derived anti-LAG3 scFv antibody targeting CD8+ T lymphocyte exhaustion 45
Tumor cells endowed with professional antigen-presenting cell functions prime PBLs to generate antitumor CTLs 32
Totale 2.558
Categoria #
all - tutte 8.792
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.792


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019174 0 0 0 0 0 0 0 0 0 0 98 76
2019/2020596 94 30 17 52 63 68 69 55 95 20 11 22
2020/2021559 18 21 27 18 173 57 50 63 12 47 10 63
2021/2022242 11 0 30 0 48 18 8 17 25 13 29 43
2022/2023405 41 92 16 43 37 70 2 24 36 3 22 19
2023/2024223 13 13 16 23 15 31 41 66 1 4 0 0
Totale 2.558